Home

Mangalam Drugs And Organics Ltd EPS

Image

Mangalam Drugs and Organics Ltd

NSE: MANGALAM

EPS

₹ -6.17

Last updated on: Oct 27, 2025

Key Highlights

  • The Earning per Share of Mangalam Drugs and Organics Ltd is ₹ -6.17 as of 27 Oct 25 .
  • The earning per share of Mangalam Drugs and Organics Ltd changed from ₹ 0.31 to ₹ -8.72 over 7 quarters. This represents a CAGR of NaN% .

Historical Earning per Share of Mangalam Drugs and Organics Ltd

No data available

* All values are in

Company Fundamentals for Mangalam Drugs and Organics Ltd

Market Cap

107 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

0.8

Day’s High

68.0

Day’s Low

63.63

DTE

0.6

ROE

4.5

52 Week High

130.0

52 Week Low

63.63

ROCE

8.1

Market Price of Mangalam Drugs and Organics Ltd

1M

1Y

3Y

5Y

Monitoring Mangalam Drugs and Organics Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
27 Oct 202567.7
24 Oct 202568.27
23 Oct 202570.02
21 Oct 202567.12
20 Oct 202570
17 Oct 202570.38
16 Oct 202569.05
15 Oct 202569.37
14 Oct 202568.3
13 Oct 202568.81

SWOT Analysis Of Mangalam Drugs and Organics Ltd

Strength

2

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Mangalam Drugs and Organics Ltd

Asset Value vs Market Value of Mangalam Drugs and Organics Ltd

Market Value

107

-0.5 X

Value addition

Asset Value

201

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Mangalam Drugs and Organics Ltd107.16
Sun Pharmaceutical Industries Ltd406471
Divis Laboratories Ltd172294
Cipla Ltd127946
Torrent Pharmaceuticals Ltd121686
Dr Reddys Laboratories Ltd107214

Historical Market Cap of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Historical Revenue of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Historical EBITDA of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Historical Net Profit of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Mangalam Drugs and Organics Ltd News Hub

Mangalam Drugs and Organics reports standalone net profit of Rs 2.68 crore in the June 2024 quarter

Net profit of Mangalam Drugs and Organics reported to Rs 2.68 crore in the quarter ended June 2024 a

Read more

14 Aug 24

Mangalam Drugs and Organics to declare Quarterly Result

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 13 Augus

Read more

10 Aug 24

Mangalam Drugs and Organics AGM scheduled

Mangalam Drugs and Organics announced that the 51th Annual General Meeting (AGM) of the company will

Read more

25 Sept 24

Mangalam Drugs and Organics announces board meeting date

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 17 May 2

Read more

15 May 25

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Mangalam Drugs and Organics Ltd

What is the EPS of Mangalam Drugs and Organics Ltd stock?

The Earnings Per Share (EPS) of Mangalam Drugs and Organics Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Mangalam Drugs and Organics Ltd EPS calculated?

The EPS of Mangalam Drugs and Organics Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Mangalam Drugs and Organics Ltd report its EPS?

Mangalam Drugs and Organics Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Mangalam Drugs and Organics Ltd EPS?

Factors that influence the EPS of Mangalam Drugs and Organics Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Mangalam Drugs and Organics Ltd EPS growth indicate future performance?

Yes, consistent growth in Mangalam Drugs and Organics Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions